127 related articles for article (PubMed ID: 22048168)
21. Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew.
Darmani NA; Janoyan JJ; Crim J; Ramirez J
Eur J Pharmacol; 2007 Jun; 563(1-3):187-96. PubMed ID: 17362921
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoid agonist WIN55,212-2 induces apoptosis in cerebellar granule cells via activation of the CB1 receptor and downregulation of bcl-xL gene expression.
Pozzoli G; Tringali G; Vairano M; D'Amico M; Navarra P; Martire M
J Neurosci Res; 2006 May; 83(6):1058-65. PubMed ID: 16609959
[TBL] [Abstract][Full Text] [Related]
23. Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon.
Mulè F; Amato A; Baldassano S; Serio R
Pharmacol Res; 2007 Aug; 56(2):132-9. PubMed ID: 17574859
[TBL] [Abstract][Full Text] [Related]
24. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
Mulè F; Amato A; Baldassano S; Serio R
Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
[TBL] [Abstract][Full Text] [Related]
25. The endocannabinoid receptors CB1 and CB2 affect the regenerative potential of adipose tissue MSCs.
Ruhl T; Karthaus N; Kim BS; Beier JP
Exp Cell Res; 2020 Apr; 389(1):111881. PubMed ID: 32006556
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoids--can what hurts you make you stronger? Commentary on the article by Alvarez et al. on page 653.
Ferriero DM
Pediatr Res; 2008 Dec; 64(6):590-1. PubMed ID: 19034198
[No Abstract] [Full Text] [Related]
27. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
Ramírez BG; Blázquez C; Gómez del Pulgar T; Guzmán M; de Ceballos ML
J Neurosci; 2005 Feb; 25(8):1904-13. PubMed ID: 15728830
[TBL] [Abstract][Full Text] [Related]
28. Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK.
Feng YJ; Li YY; Lin XH; Li K; Cao MH
World J Gastroenterol; 2016 Nov; 22(43):9515-9524. PubMed ID: 27920472
[TBL] [Abstract][Full Text] [Related]
29. WIN induces apoptotic cell death in human colon cancer cells through a block of autophagic flux dependent on PPARγ down-regulation.
Pellerito O; Notaro A; Sabella S; De Blasio A; Vento R; Calvaruso G; Giuliano M
Apoptosis; 2014 Jun; 19(6):1029-42. PubMed ID: 24696378
[TBL] [Abstract][Full Text] [Related]
30. Cannabinoids in the treatment of cancer.
Alexander A; Smith PF; Rosengren RJ
Cancer Lett; 2009 Nov; 285(1):6-12. PubMed ID: 19442435
[TBL] [Abstract][Full Text] [Related]
31. Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts.
Garcia-Gonzalez E; Selvi E; Balistreri E; Lorenzini S; Maggio R; Natale MR; Capecchi PL; Lazzerini PE; Bardelli M; Laghi-Pasini F; Galeazzi M
Rheumatology (Oxford); 2009 Sep; 48(9):1050-6. PubMed ID: 19589890
[TBL] [Abstract][Full Text] [Related]
32. Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor.
Paugh SW; Cassidy MP; He H; Milstien S; Sim-Selley LJ; Spiegel S; Selley DE
Mol Pharmacol; 2006 Jul; 70(1):41-50. PubMed ID: 16571654
[TBL] [Abstract][Full Text] [Related]
33. Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative.
Silva NR; Gomes FV; Fonseca MD; Mechoulam R; Breuer A; Cunha TM; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):369-377. PubMed ID: 28720466
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of synthetic cannabinoids on cytokine production in rheumatoid fibroblast-like synoviocytes.
Selvi E; Lorenzini S; Garcia-Gonzalez E; Maggio R; Lazzerini PE; Capecchi PL; Balistreri E; Spreafico A; Niccolini S; Pompella G; Natale MR; Guideri F; Laghi Pasini F; Galeazzi M; Marcolongo R
Clin Exp Rheumatol; 2008; 26(4):574-81. PubMed ID: 18799087
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and pharmacological evaluation of analogs of indole-based cannabimimetic agents.
Mazzoni O; Diurno MV; di Bosco AM; Novellino E; Grieco P; Esposito G; Bertamino A; Calignano A; Russo R
Chem Biol Drug Des; 2010 Jan; 75(1):106-14. PubMed ID: 19895505
[TBL] [Abstract][Full Text] [Related]
36. The synthetic cannabinoid WIN-55,212 induced-apoptosis in cytotrophoblasts cells by a mechanism dependent on CB1 receptor.
Almada M; Costa L; Fonseca BM; Amaral C; Teixeira N; Correia-da-Silva G
Toxicology; 2017 Jun; 385():67-73. PubMed ID: 28495606
[TBL] [Abstract][Full Text] [Related]
37. Cannabinoid receptor agonists potentiate action potential-independent release of GABA in the dentate gyrus through a CB1 receptor-independent mechanism.
Hofmann ME; Bhatia C; Frazier CJ
J Physiol; 2011 Aug; 589(Pt 15):3801-21. PubMed ID: 21646412
[TBL] [Abstract][Full Text] [Related]
38. Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1.
Kong Y; Wang W; Zhang C; Wu Y; Liu Y; Zhou X
Mol Med Rep; 2016 Jun; 13(6):4569-76. PubMed ID: 27082728
[TBL] [Abstract][Full Text] [Related]
39. Potentiation of cannabinoid-induced cytotoxicity in mantle cell lymphoma through modulation of ceramide metabolism.
Gustafsson K; Sander B; Bielawski J; Hannun YA; Flygare J
Mol Cancer Res; 2009 Jul; 7(7):1086-98. PubMed ID: 19609004
[TBL] [Abstract][Full Text] [Related]
40. Chronic exposure to cannabinoids before an emotional trauma may have negative effects on emotional function.
Sbarski B; Akirav I
Eur Neuropsychopharmacol; 2018 Aug; 28(8):955-969. PubMed ID: 30026011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
